WBMD » Topics » PART II OTHER INFORMATION

This excerpt taken from the WBMD 10-Q filed May 11, 2009.
PART II
OTHER INFORMATION
 
ITEM 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
(c) The following table provides information about purchases by WebMD during the three months ended March 31, 2009 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act:
 
This excerpt taken from the WBMD 10-Q filed Aug 11, 2008.
PART II
OTHER INFORMATION
 
ITEM 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
(c)   Issuer Purchases of Equity Securities
 
During the three months ended June 30, 2008, 847 shares were withheld from WebMD Restricted Stock that vested on June 11, 2008 and on June 18, 2008, in order to satisfy withholding tax requirements related to the vesting of the awards. The value of these shares which was $28,214 in the aggregate, was determined based on the closing fair market value of our Class A common stock on the date of vesting, which was: $33.17 per share on June 11, 2008 and $34.41 per share on June 18, 2008. These were the only repurchases of equity securities made by us during the three months ended June 30, 2008. We do not have a repurchase program.
 
ITEM 6.   Exhibits
 
The exhibits listed in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.


60


Table of Contents

PART II
OTHER INFORMATION
 
ITEM 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
(c)   Issuer Purchases of Equity Securities
 
During the three months ended March 31, 2008, 3,571 shares were withheld from WebMD Restricted Stock that vested on January 17, 2008, on March 12, 2008, on March 14, 2008 and on March 27, 2008, in order to satisfy withholding tax requirements related to the vesting of the awards. The value of these shares, which was $119,827 in the aggregate, was determined based on the closing fair market value of our Class A Common Stock on the date of vesting, which was: $38.22 per share on January 17, 2008; $24.87 per share on March 12, 2008; $25.99 per share on March 14, 2008; and $24.59 per share on March 27, 2008. These were the only repurchases of equity securities made by us during the three months ended March 31, 2008. We do not have a repurchase program.
 
ITEM 6.   Exhibits
 
The exhibits listed in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.


58


Table of Contents

PART II
OTHER INFORMATION
 
ITEM 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
(c)   Issuer Purchases of Equity Securities
 
During the three months ended June 30, 2007, 97 shares were withheld from WebMD Restricted Stock that vested on April 3, 2007, in order to satisfy withholding tax requirements related to the vesting of the awards. The value of these shares was determined based on $53.07 per share, the closing fair market value of our Class A common stock on April 3, 2007. These were the only repurchases of equity securities made by us during the three months ended June 30, 2007. We do not have a repurchase program.
 
ITEM 6.   Exhibits
 
The exhibits listed in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.


50


Table of Contents

PART II
OTHER INFORMATION
 
ITEM 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
(c)   Issuer Purchases of Equity Securities
 
During the three months ended March 31, 2007, 5,158 shares were withheld from WebMD Restricted Stock that vested on January 17, 2007 and on March 27, 2007, in order to satisfy withholding tax requirements related to the vesting of the awards. The value of these shares was determined based on $43.84 per share and $51.48 per share, the closing fair market value of our Class A common stock on January 17, 2007 and March 27, 2007, respectively. These were the only repurchases of equity securities made by us during the three months ended March 31, 2007. We do not have a repurchase program.
 
PART II
OTHER INFORMATION
 
ITEM 1.   Legal Proceedings
 
The information contained in Note 10 to the Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report is incorporated herein by this reference.
 
ITEM 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki